TickerFacts.

Medpace Holdings, Inc. (MEDP): Revenue

Annual figures by period end, from SEC filings.

$2.53B
Year ended 2025-12-31
$2.78B
Trailing 12 months to 2026-06-30
+20.1%
3-year compound annual growth
+22.3%
5-year compound annual growth
+21.6%
10-year compound annual growth
2015-12-31: $359.06M2016-12-31: $421.58M2017-12-31: $436.15M2018-12-31: $704.59M2019-12-31: $860.97M2020-12-31: $925.92M2021-12-31: $1.14B2022-12-31: $1.46B2023-12-31: $1.89B2024-12-31: $2.11B2025-12-31: $2.53B$2.53B
2015-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$2.53B+20.0%2026-02-10, From 2025-01-01
2024-12-31$2.11B+11.8%2026-02-10, From 2024-01-01
2023-12-31$1.89B+29.2%2026-02-10, From 2023-01-01
2022-12-31$1.46B+27.8%2025-02-11, From 2022-01-01
2021-12-31$1.14B+23.4%2024-02-13, From 2021-01-01
2020-12-31$925.92M+7.5%2023-02-14, From 2020-01-01
2019-12-31$860.97M+22.2%2022-02-15, From 2019-01-01
2018-12-31$704.59M+61.5%2021-02-16, From 2018-01-01
2017-12-31$436.15M+3.5%2020-02-25, From 2017-01-01
2016-12-31$421.58M+17.4%2019-02-26, From 2016-01-01
2015-12-31$359.06Mn/a2018-02-27, From 2015-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Medpace Holdings, Inc. (MEDP)2025-12-31$2.53B+20.0%
Charles River Laboratories International, Inc. (CRL)2025-12-27$4.02B-0.9%
Incyte Corp (INCY)2025-12-31$5.14B+21.2%
Icon PLC (ICLR)2025-12-31$8.25B+0.8%
Iqvia Holdings Inc. (IQV)2025-12-31$16.31B+5.9%
NRC Health (NRC)2025-12-31$137.39M-4.0%
MaxCyte, Inc. (MXCT)2025-12-31$33.03M-14.5%
OmniAb, Inc. (OABI)2025-12-31$18.67M-29.3%
Foxo Technologies Inc. (FOXO)2025-12-31$16.37M+304.0%

Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗